Loading
Latest filing published 08 Dec 2020 for Khiron Life Sciences Corp., €5,119.
No signal scores available.
This profile gathers the share dealings of Tejinder Virk in Khiron Life Sciences Corp. In total, 2 filings cover trades dated from 1 October 2019 to 4 December 2020.
No open-market sale appears; the market trades are 1 purchase worth €5,119. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2020 alone, the filings show 1 purchase and no sales.
On 8 December 2020 came the latest disclosure, an open-market purchase for €5,119 in Khiron Life Sciences Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations